Over 1.26 lakh beneficiaries receive medical aid in Prakasam district under government schemes
More than 1.26 lakh people in Prakasam district received medical assistance worth ₹292 crore through Ayushman Bharat and Dr. NTR Vaidya Seva schemes via 97 hospitals since the coalition government's formation. The district also achieved 100% institutional delivery rates and registered 25,735 pregnancies in 2025-26, with 6,205 identified as high-risk cases. The review highlights progress in healthcare, education, and infrastructure development as part of the state's broader development agenda.
Officials in Prakasam district reported that over 1.26 lakh beneficiaries have received medical assistance worth ₹292 crore through Ayushman Bharat and Dr. NTR Vaidya Seva schemes across 97 empanelled hospitals since the coalition government's formation. The district achieved 100% institutional delivery rates with 22,668 deliveries in healthcare institutions, while 6,205 of 25,735 registered pregnancies were identified as high-risk and provided specialized care. Beyond healthcare, the review covered education initiatives including reduced student dropout rates through schemes like Talliki Vandanam and the Dokka Seethamma Mid-Day Meal scheme, with 619 teachers recruited through DSC examinations. The district operates 1,980 government schools and 87 colleges with 1.86 lakh total student enrollment. Infrastructure improvements are being implemented through PM SHRI Schools and other programs, with surprise inspections announced to assess school quality and performance.
What different sources said
- The HinduCenter
Over 1.26 lakh receive medical aid in Prakasam district
Related
Multi-Cancer Blood Test Galleri Fails Primary Trial Endpoint
A major clinical trial of Galleri, a blood test designed to detect multiple cancers early, failed to meet its primary goal of reducing late-stage cancer diagnoses when results were announced in February. Multi-cancer early detection (MCED) tests aim to improve survival rates by identifying disease at earlier, more treatable stages. The failure raises questions about the effectiveness of this promising diagnostic approach despite initial scientific enthusiasm.
Study Uses CPAP Data to Measure Social Jet Lag in Sleep Apnea Patients
Researchers analyzed CPAP adherence records from nearly 3,000 obstructive sleep apnea patients to measure social jet lag—the circadian misalignment between work and free days. About 16-21% of patients showed moderate to severe social jet lag, with prevalence highest in younger and middle-aged adults and declining after age 65. The findings suggest CPAP devices could routinely screen for circadian misalignment, potentially identifying patients who need additional behavioral or activity-based interventions.
FDA Updates Alli Label to Warn of Rare but Potentially Fatal Kidney Problems
The FDA has approved updated labeling for Alli, an over-the-counter weight loss pill, to warn of rare risks including acute kidney injury, kidney stones, and oxalate nephropathy. The agency now instructs people with kidney disease history to consult a doctor before use and directs all users to stop taking the drug if they experience symptoms like back pain, blood in urine, or leg swelling. This warning is significant because Alli is the only OTC weight loss medication available in the U.S., and approximately 40 million people have used orlistat (Alli's generic form) since its approval in 1999.